Back
Defiance Daily Target 2X Long Uranium ETF Vs. Collegium Pharmaceutical Industry Stock Comparison
Sell
36
URAX
Defiance Daily Target 2X Long Uranium ETF
Last Price:
$12.56
Seasonality Move:
--
Sell
45
COLL
Collegium Pharmaceutical
Last Price:
$33.33
Seasonality Move:
-1.63%
Sell
36
Defiance Daily Target 2X Long Uranium ETF (URAX)
is a Sell
Is Defiance Daily Target 2X Long Uranium ETF a Buy, Sell or Hold?
-
The current Defiance Daily Target 2X Long Uranium ETF [URAX] share price is $13.14. The Score for URAX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
URAX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Collegium Pharmaceutical (COLL)
is a Sell
Is Collegium Pharmaceutical a Buy, Sell or Hold?
-
The current Collegium Pharmaceutical [COLL] share price is $33.34. The Score for COLL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
COLL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
URAX Stock Price Chart
What is Defiance Daily Target 2X Long Uranium ETF's stock price today?
-
The Defiance Daily Target 2X Long Uranium ETF share price today is $13.14Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URAX is experiencing slight buying pressure.
COLL Stock Price Chart
What is Collegium Pharmaceutical's stock price today?
-
The Collegium Pharmaceutical share price today is $33.34Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and COLL is experiencing buying pressure, which is a positive indicator for future bullish movement.
URAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.72 | Sell |
Relative Strength Index (14 RSI): | 41.22 | Sell |
Chaikin Money Flow: | 8698 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (12.9 - 16.16) | Sell |
Bollinger Bands (100): | (12.36 - 17.2) | Sell |
COLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.27 | Sell |
Relative Strength Index (14 RSI): | 66.05 | Buy |
Chaikin Money Flow: | 1007158 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.9 - 30.94) | Buy |
Bollinger Bands (100): | (30.52 - 37.92) | Sell |
URAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.35 | Sell |
20-day SMA: | 13.86 | Sell |
50-day SMA: | 15.71 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 13.51 | Sell |
20-day EMA: | 14.06 | Sell |
50-day EMA: | 14.96 | Sell |
200-day EMA: | 7.86 | Buy |
COLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 29.45 | Buy |
20-day SMA: | 29.79 | Buy |
50-day SMA: | 30.91 | Buy |
200-day SMA: | 34.47 | Sell |
8-day EMA: | 30.02 | Buy |
20-day EMA: | 29.94 | Buy |
50-day EMA: | 31.21 | Buy |
200-day EMA: | 32.94 | Buy |
Defiance Daily Target 2X Long Uranium ETF Earnings Growth & URAX Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Collegium Pharmaceutical Earnings Growth & COLL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.42 per share, and an increase next year of $0.51 per share.
Defiance Daily Target 2X Long Uranium ETF Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Collegium Pharmaceutical Technical Analysis
Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | Jan 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |